• Contact Us
  • About
  • Advertise
  • Careers
Kashmir Dot Com
  • Home
  • Kashmir
  • Jammu
  • World
  • Politics
  • Opinion
  • Business
  • Health
  • Contact Us
No Result
View All Result
  • Home
  • Kashmir
  • Jammu
  • World
  • Politics
  • Opinion
  • Business
  • Health
  • Contact Us
No Result
View All Result
Kashmir Dot Com
No Result
View All Result
Home Health

‘Serious issue’: Dolo-650 makers spent Rs 1000 cr freebies on docs to prescribe drug

Kashmir Dot Com by Kashmir Dot Com
August 19, 2022
in Health
0
Redrawing of constituencies: Petition filed by 2 Srinagar residents dismissed by Supreme Court

File Image

0
SHARES
111
VIEWS
Share on Facebook

The Supreme Court was told on Thursday that the Central Board for Direct Taxes (CBDT) has accused makers of Dolo-650 tablet of distributing freebies around Rs 1,000 crore to doctors as consideration for prescribing the tablet.

Senior advocate Sanjay Parikh, representing Federation of Medical & Sales Representatives Association of India, contended before a bench headed by justice D.Y. Chandrachud that Dolo had invested Rs 1,000 core in freebies to have its anti-fever drug prescribed to patients.

Justice Chandrachud said that it is a serious issue and even he was prescribed the same during Covid and said, “I was also asked to have the same when I had Covid.” He added, “This is a serious issue and matter.”

The bench, also comprising justice A.S. Bopanna, asked Additional Solicitor General K.M. Natraj, representing the Centre, to file a reply within 10 days.

The apex court was hearing a PIL seeking directions to make pharmaceutical companies liable for giving freebies to doctors as incentive to prescribe their drugs.

The plea said: “Petitioners seek enforcement of the fundamental right to health enshrined in the Right to Life under Article 21 of the Constitution of India in view of the ever-increasing instances of unethical marketing practices by Pharmaceutical Companies in their dealings with healthcare professionals resulting in prescription of excessive and/or irrational drugs and a push for high-cost and/or over-priced brands, which are practices that directly affect citizens’ health, violating their rights under Article 21 of Constitution.”

The plea contended that it is high time that the lacuna in ensuring the right to health is urgently filled up by an appropriate legislation. The plea added that there are abundant examples that show how corruption in the pharmaceutical sector endangers positive health outcomes and puts patients’ health at risk.

“As violations of this kind have become a recurring phenomenon and are progressively becoming more pervasive, the petitioners pray that a Statutory Code of ethical marketing for the pharmaceutical industry, with penal consequences, be established to curb such practices for the enforcement of the fundamental Right to Health of the people of India,” added the plea.

The plea argued that due to the voluntary nature of the existing code, unethical practices continue to increase and have also surfaced during the COVID-19 times.

Tags: Dolo-650Supreme Court
Previous Post

Gold falls Rs 389; silver plunges Rs 1,607

Next Post

Lt Governor releases Hindi Ghazal anthology of Satish Vimal

Next Post
Lt Governor releases Hindi Ghazal anthology of Satish Vimal

Lt Governor releases Hindi Ghazal anthology of Satish Vimal

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

ADVERTISEMENT

LATEST NEWS

Centre Transfers Three IAS Officers from Delhi to Jammu and Kashmir

J&K SEC Shantmanu attends meeting with President at Rashtrapati Bhavan

Spl Secy Cabinet Secretariat reviews deregulation reforms with Chief Secretary Dr. Sajjan

IndiGo cancels Saudi Arabia flights till Nov 30

FDA Seals Hattrick’s Storage Area in Rajbagh Over Food Safety Violations; 69 Inspections Conducted Across J&K

JKSA Slams BGSBU VC Over Invitation to RSS Pracharak Indresh Kumar as Chief Guest, Seeks Probe

SMC Seals Unauthorised Car Washing Centre in Srinagar’s Natipora

NIT Srinagar selects three teams for National-Level Design for Bharat 2027 challenge

Article 21 means nothing but lip service if police fancy dictates preventive detention: J&K High Court

Only Handful of Foreign Terrorists Remain in J&K, UT Will Soon Be Terror-Free: LG Sinha

Facebook Twitter

About Us

Kashmir Dot Com (KDC) is J&K's premier News Agency having a vast reach of audience.

Kashmir Dot Com is a News Agency based in Srinagar, J&K that offers syndicated multimedia news feed to plethora of news-bureaus in J&K and beyond. We also provide a range of facilities from foreign and domestic channels to package their reports in Jammu and Kashmir. We cover almost all areas of interest in J&K to viewers including news, entertainment, and life styles, bussiness, sports, human-interest features and social and developmental issues.

KDC can well and truly take pride in the legacy of it's work, and in it's contribution towards the building of a free and fair Press in Jammu and Kashmir.

Category

  • Business
  • Entertainment
  • Health
  • JAMMU
  • Kashmir
  • Lead
  • National
  • Opinion
  • Politics
  • Science
  • Sports
  • Tech
  • Uncategorized
  • World

Company Info

  • Contact Us
  • About
  • Advertise
  • Careers

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.

error: Content is protected !!
No Result
View All Result
  • Home
  • Kashmir
  • Jammu
  • World
  • Politics
  • Opinion
  • Business
  • Health
  • Contact Us

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.